Literature DB >> 19237918

Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat.

Damien Roux1, Stéphane Gaudry, Didier Dreyfuss, Jamel El-Benna, Nicolas de Prost, Erick Denamur, Georges Saumon, Jean-Damien Ricard.   

Abstract

OBJECTIVE: To determine whether Candida albicans airway colonization influences Pseudomonas aeruginosa pneumonia prevalence in rats and by which mechanism.
DESIGN: Prospective, randomized, controlled animal study.
SETTING: Research laboratory of a university.
SUBJECTS: Male adult Wistar rats weighing 275-300 g.
INTERVENTIONS: In vivo: P. aeruginosa pneumonia was induced by bronchial instillation of P. aeruginosa in rats previously instilled or not with live or ethanol-killed C. albicans. In vitro: Alveolar macrophages were incubated with or without live or ethanol-killed C. albicans.
MEASUREMENTS AND MAIN RESULTS: Quantitative cultures of lung were done. Lung tumor necrosis factor alpha, interferon gamma, and interleukin-6 levels were measured along with reactive oxygen species (ROS) production by alveolar macrophages. P. aeruginosa pneumonia prevalence was higher in rats given live but not ethanol-killed C. albicans. Instilling live C. albicans alone increased lung tumor necrosis factor-alpha and interferon-gamma but not interleukin-6, and was not associated with clinical or histologic signs of infection. These three cytokines were more abundant in lungs instilled with live C. albicans and P. aeruginosa than in those instilled with P. aeruginosa alone or with ethanol-killed C. albicans and P. aeruginosa. Alveolar macrophages incubated with live C. albicans had decreased ROS production.
CONCLUSIONS: C. albicans impedes alveolar macrophage ROS production and is correlated with an increase of P. aeruginosa pneumonia prevalence in rats. These results highlight the previously overlooked impact of airway fungal colonization on lung bacterial infection, and indicate the need for studies on the potential for antifungal therapy to prevent the onset of ventilator-associated pneumonia caused by P. aeruginosa.

Entities:  

Mesh:

Year:  2009        PMID: 19237918     DOI: 10.1097/CCM.0b013e31819629d2

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  46 in total

Review 1.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

2.  Candida colonization in ventilated ICU patients: no longer a bystander!

Authors:  Jean-Damien Ricard; Damien Roux
Journal:  Intensive Care Med       Date:  2012-06-15       Impact factor: 17.440

3.  Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study.

Authors:  W Meersseman; K Lagrou; I Spriet; J Maertens; E Verbeken; W E Peetermans; E Van Wijngaerden
Journal:  Intensive Care Med       Date:  2009-04-09       Impact factor: 17.440

4.  Candida pneumonia in the ICU: myth or reality?

Authors:  Jean-Damien Ricard; Damien Roux
Journal:  Intensive Care Med       Date:  2009-06-27       Impact factor: 17.440

5.  Severe hospital-acquired pneumonia: a review for clinicians.

Authors:  John Dallas; Marin Kollef
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

6.  Ask the wrong question, you'll the get the wrong answer.

Authors:  Damien Roux; Jean-Damien Ricard
Journal:  Intensive Care Med       Date:  2014-08-20       Impact factor: 17.440

7.  Candida colonization of respiratory tract: to treat or not to treat, will we ever get an answer?

Authors:  Gennaro De Pascale; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2014-07-01       Impact factor: 17.440

8.  Candida in the respiratory tract secretions of critically ill patients and the impact of antifungal treatment: a randomized placebo controlled pilot trial (CANTREAT study).

Authors:  Martin Albert; David Williamson; John Muscedere; Francois Lauzier; Coleman Rotstein; Salmaan Kanji; Xuran Jiang; Mark Hall; Daren Heyland
Journal:  Intensive Care Med       Date:  2014-07-01       Impact factor: 17.440

9.  Candida albicans and Pseudomonas aeruginosa Interact To Enhance Virulence of Mucosal Infection in Transparent Zebrafish.

Authors:  Audrey C Bergeron; Brittany G Seman; John H Hammond; Linda S Archambault; Deborah A Hogan; Robert T Wheeler
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

10.  Impact of Candida species on clinical outcomes in patients with suspected ventilator-associated pneumonia.

Authors:  Marie-Soleil Delisle; David R Williamson; Martin Albert; Marc M Perreault; Xuran Jiang; Andrew G Day; Daren K Heyland
Journal:  Can Respir J       Date:  2011 May-Jun       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.